Bristol-Myers Squibb Company vs Bank of Montreal
Market cap comparison over time
Bristol-Myers Squibb Company
$116.2B
Rank #138
Bank of Montreal
$118.8B
Rank #133
Market Cap Over Time
Key Moments
- Bank of Montreal overtook Bristol-Myers Squibb Company by 2026
Year-by-Year Comparison
| Year | Bristol-Myers Squibb Company | Bank of Montreal | Leader |
|---|---|---|---|
| 2026 | $116.2B | $118.8B | Bank of Montreal |
| 2025 | $107.8B | $89.6B | Bristol-Myers Squibb Company |
| 2024 | $107.6B | $67.2B | Bristol-Myers Squibb Company |
| 2023 | $92.9B | $60.2B | Bristol-Myers Squibb Company |
| 2022 | $125.8B | $53.6B | Bristol-Myers Squibb Company |
| 2021 | $105.8B | $57.2B | Bristol-Myers Squibb Company |
| 2020 | $102.0B | $39.2B | Bristol-Myers Squibb Company |
| 2019 | $102.4B | $38.7B | Bristol-Myers Squibb Company |
| 2018 | $80.2B | $32.9B | Bristol-Myers Squibb Company |
| 2017 | $92.0B | $35.8B | Bristol-Myers Squibb Company |
| 2016 | $85.4B | $33.1B | Bristol-Myers Squibb Company |
| 2015 | $98.2B | $25.7B | Bristol-Myers Squibb Company |
| 2014 | $82.3B | $25.9B | Bristol-Myers Squibb Company |
| 2013 | $72.0B | $21.4B | Bristol-Myers Squibb Company |
| 2012 | $42.7B | $17.6B | Bristol-Myers Squibb Company |
| 2011 | $44.4B | $15.4B | Bristol-Myers Squibb Company |
| 2010 | $31.8B | $15.2B | Bristol-Myers Squibb Company |
| 2009 | $28.9B | $14.1B | Bristol-Myers Squibb Company |
| 2008 | $25.1B | $7.4B | Bristol-Myers Squibb Company |
| 2007 | $27.1B | $12.5B | Bristol-Myers Squibb Company |
| 2006 | $25.9B | $14.7B | Bristol-Myers Squibb Company |
| 2005 | $21.6B | $13.4B | Bristol-Myers Squibb Company |
| 2004 | $23.0B | $11.5B | Bristol-Myers Squibb Company |
| 2003 | $24.5B | $10.4B | Bristol-Myers Squibb Company |
| 2002 | $19.0B | $7.9B | Bristol-Myers Squibb Company |
| 2001 | $40.3B | $6.5B | Bristol-Myers Squibb Company |
| 2000 | $54.6B | $7.0B | Bristol-Myers Squibb Company |
| 1999 | $46.6B | $4.2B | Bristol-Myers Squibb Company |
| 1998 | $48.0B | $5.1B | Bristol-Myers Squibb Company |
| 1997 | $33.4B | $5.1B | Bristol-Myers Squibb Company |
| 1996 | $18.8B | $3.4B | Bristol-Myers Squibb Company |
| 1995 | $14.3B | $2.4B | Bristol-Myers Squibb Company |